R-Ras is regulated by activators and effectors distinct from those that control Ras function - PubMed (original) (raw)
. 1997 Jan 16;14(2):133-43.
doi: 10.1038/sj.onc.1200815.
Affiliations
- PMID: 9010215
- DOI: 10.1038/sj.onc.1200815
R-Ras is regulated by activators and effectors distinct from those that control Ras function
S Y Huff et al. Oncogene. 1997.
Abstract
Like Ras, constitutively activated mutants of the Ras-related protein R-Ras cause tumorigenic transformation of NIH3T3 cells. However, since R-Ras causes a transformed phenotype distinct from that induced by Ras, it is likely that R-Ras controls signaling pathways and cellular processes distinct from those regulated by Ras. To address this possibility, we determined if R-Ras is regulated by activators and effectors distinct from those that regulate Ras function. We observed that Ras guanine nucleotide exchange factors failed to activate R-Ras in vivo, indicating that R-Ras is activated by distinct GEFs. Consistent with this, mutants of R-Ras with mutations analogous to the Ras(15A)/(17N) dominant negative proteins did not antagonize Ras GEF function and lacked the growth inhibitory activity seen with these mutant Ras proteins. Thus, R-Ras, but not Ras, is dispensable for the viability of NIH3T3 cells. Finally, whereas constitutively activated Ras can overcome the growth inhibitory action of the Ras(17N) dominant negative protein via Raf-dependent and -independent activities, transforming mutants of R-Ras failed to do so. This inability was consistent with our observation that Ras-, but not R-Ras-transformed, NIH3T3 cells possessed constitutively upregulated Raf kinase activities. Thus, R-Ras and Ras are regulators of distinct signaling pathways and cellular processes.
Similar articles
- Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
Movilla N, Crespo P, Bustelo XR. Movilla N, et al. Oncogene. 1999 Oct 21;18(43):5860-9. doi: 10.1038/sj.onc.1202968. Oncogene. 1999. PMID: 10557073 - TC21 and Ras share indistinguishable transforming and differentiating activities.
Graham SM, Oldham SM, Martin CB, Drugan JK, Zohn IE, Campbell S, Der CJ. Graham SM, et al. Oncogene. 1999 Mar 25;18(12):2107-16. doi: 10.1038/sj.onc.1202517. Oncogene. 1999. PMID: 10321735 - Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes.
Saez R, Chan AM, Miki T, Aaronson SA. Saez R, et al. Oncogene. 1994 Oct;9(10):2977-82. Oncogene. 1994. PMID: 8084601 - Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
Zohn IM, Campbell SL, Khosravi-Far R, Rossman KL, Der CJ. Zohn IM, et al. Oncogene. 1998 Sep 17;17(11 Reviews):1415-38. doi: 10.1038/sj.onc.1202181. Oncogene. 1998. PMID: 9779988 Review. - Signaling molecules that mediate the actions of FGF.
Demo SD, Kikuchi A, Peters KG, MacNicol AM, Muslin AJ, Williams LT. Demo SD, et al. Princess Takamatsu Symp. 1994;24:243-9. Princess Takamatsu Symp. 1994. PMID: 8983079 Review.
Cited by
- Regulation of H-Ras-driven MAPK signaling, transformation and tumorigenesis, but not PI3K signaling and tumor progression, by plasma membrane microdomains.
Michael JV, Wurtzel JG, Goldfinger LE. Michael JV, et al. Oncogenesis. 2016 May 30;5(5):e228. doi: 10.1038/oncsis.2016.36. Oncogenesis. 2016. PMID: 27239960 Free PMC article. - R-Ras regulates beta1-integrin trafficking via effects on membrane ruffling and endocytosis.
Conklin MW, Ada-Nguema A, Parsons M, Riching KM, Keely PJ. Conklin MW, et al. BMC Cell Biol. 2010 Feb 18;11:14. doi: 10.1186/1471-2121-11-14. BMC Cell Biol. 2010. PMID: 20167113 Free PMC article. - Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism.
Ramos JW, Hughes PE, Renshaw MW, Schwartz MA, Formstecher E, Chneiweiss H, Ginsberg MH. Ramos JW, et al. Mol Biol Cell. 2000 Sep;11(9):2863-72. doi: 10.1091/mbc.11.9.2863. Mol Biol Cell. 2000. PMID: 10982386 Free PMC article. - R-Ras promotes metastasis of cervical cancer epithelial cells.
Mora N, Rosales R, Rosales C. Mora N, et al. Cancer Immunol Immunother. 2007 Apr;56(4):535-44. doi: 10.1007/s00262-006-0205-z. Epub 2006 Jul 22. Cancer Immunol Immunother. 2007. PMID: 16862428 Free PMC article. - Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells.
Huang Y, Rangwala F, Fulkerson PC, Ling B, Reed E, Cox AD, Kamholz J, Ratner N. Huang Y, et al. Oncogene. 2004 Jan 15;23(2):368-78. doi: 10.1038/sj.onc.1207075. Oncogene. 2004. PMID: 14724565 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous